KeHua Biology: Luo Fang resigned as Chief Financial Officer, and Zang Xianfeng took over.

On July 31st, Kexin Biotech announced that the Board of Directors recently received a written resignation report from the Chief Financial Officer, Luo Fang. Luo Fang resigned from the position of Chief Financial Officer due to retirement, and also resigned from other positions in the company's subsidiary. The resignation report will take effect from the date of delivery to the Board of Directors. The company held the 14th meeting of the 10th Board of Directors on July 31, 2025, and approved the "Proposal on the Appointment of the Chief Financial Officer of the Company," appointing Zang Xianfeng as the Chief Financial Officer of the company. The term of office will start from the date of approval by the current Board of Directors until the end of the term of the 10th Board of Directors.